By contrast, Lee et al. observed a CD8+ T cell-dependent immunity and tumor reduction, together with a reduced relapse of the primary tumor, as well as an eradication of metastases in some cases particular after high dose or ablative RT with 1 × 15–25 Gy in various cancer models. Here, CD8A is linked to neoplasm.